Announced Wed, 1 Apr · 18:25 IST
Re-appointment of Mr. Pranav Amin as Managing Director for 5 years
Management Changes View source PDF
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹673.00
prior close
₹666.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-1.4-1.7-1.5-2.4+3.0+9.1+7.0+7.3+8.5+13.2+13.9+8.3+21.8
Up moveDown movePending
AI summary
Alembic Pharmaceuticals has formally notified that Mr. Pranav Amin's re-appointment as Managing Director is effective from April 1, 2026, for a 5-year term. The re-appointment was earlier approved by shareholders at the 15th AGM on August 5, 2025. Mr. Pranav Amin heads the company's international business and is the son of Chairman Mr. Chirayu Amin and brother of MD Mr. Shaunak Amin. The company confirmed he is not debarred by SEBI from holding the position.
Likely market impact
Continuity at the top; provides leadership stability for the next 5 years, with promoter-family MDs continuing to drive the company.